UK veterinary group CVS targeted by activist investor
Converium Capital complains vet company’s stock has not recovered after UK regulators finished an industry probe
Related reading
UK vets face price caps after competition review
Watchdog finds regulatory system is ‘not fit for purpose’ but stops short of proposing structural reform of sector
US vaccine overhaul unnerves investors as sceptics seize advisory posts
Vaccine businesses seen as valuable parts of pharma groups but government hostility could deter future developments
CVC targets 401k retirement market after Trump opens pensions to private equity
Value of realised investments jumps 20 per cent to record €13.2bn but performance-related earnings fall in first half
KKR nears Viridor stake sale to Equitix
Private capital firm explored both £7bn sale and partial disposal of UK waste management group
The CVC conundrum: fund investors love it, public markets don’t
The private equity firm is good at buyouts, but in an era when diversity is prized, that might not be enough to prop up its shares
UK regulator pushes private credit groups to share more data
Fast-growing market comes under greater scrutiny for potential risks after series of setbacks